SATSUMA PHARMACEUTICALS

satsuma-pharmaceuticals-logo

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.

#SimilarOrganizations #People #Financial #Event #Website #More

SATSUMA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2016-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.satsumarx.com

Total Employee:
1+

Status:
Active

Contact:
650.410.3200

Total Funding:
154 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag


Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

shuttle-pharmaceuticals-logo

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.

sparrow-pharmaceuticals-logo

Sparrow Pharmaceuticals

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.


Current Advisors List

rajeev-shah_image

Rajeev Shah Board Of Directors @ Satsuma Pharmaceuticals
Board_member

john-kollins_image

John Kollins Board Member @ Satsuma Pharmaceuticals
Board_member
2016-01-01

heath-lukatch_image

Heath Lukatch Board Of Directors @ Satsuma Pharmaceuticals
Board_member

Current Employees Featured

john-kollins_image

John Kollins
John Kollins Cofounder, President & CEO @ Satsuma Pharmaceuticals
Cofounder, President & CEO
2016-06-01

not_available_image

Detlef Albrecht
Detlef Albrecht Chief Medical Officer @ Satsuma Pharmaceuticals
Chief Medical Officer
2017-06-01

rob-janosky_image

Rob Janosky
Rob Janosky Chief Commercial Officer @ Satsuma Pharmaceuticals
Chief Commercial Officer
2020-03-01

Founder


john-kollins_image

John Kollins

Stock Details


Company's stock symbol is NASDAQ:STSA

Investors List

commodore-capital_image

Commodore Capital

Commodore Capital investment in Post-IPO Equity - Satsuma Pharmaceuticals

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Post-IPO Equity - Satsuma Pharmaceuticals

shin-nippon-biomedical-laboratories_image

Shin Nippon Biomedical Laboratories (SNBL)

Shin Nippon Biomedical Laboratories (SNBL) investment in Post-IPO Equity - Satsuma Pharmaceuticals

logos-capital_image

Logos Capital

Logos Capital investment in Post-IPO Equity - Satsuma Pharmaceuticals

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Equity - Satsuma Pharmaceuticals

aspire-capital-fund_image

Aspire Capital Partners LLC

Aspire Capital Partners LLC investment in Post-IPO Equity - Satsuma Pharmaceuticals

vivo-capital_image

Vivo Capital

Vivo Capital investment in Post-IPO Equity - Satsuma Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Satsuma Pharmaceuticals

point72_image

Point72

Point72 investment in Post-IPO Equity - Satsuma Pharmaceuticals

ghost-tree-capital-group_image

Ghost Tree Capital Group

Ghost Tree Capital Group investment in Post-IPO Equity - Satsuma Pharmaceuticals

Key Employee Changes

Date New article
2020-03-05 Satsuma Pharmaceuticals Appoints Rob Janosky as Chief Commercial Officer

Official Site Inspections

http://www.satsumarx.com Semrush global rank: 7.43 M Semrush visits lastest month: 498

  • Host name: 37.172.196.104.bc.googleusercontent.com
  • IP address: 104.196.172.37
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Satsuma Pharmaceuticals" on Search Engine